Malvern antibiotics developer Venatorx lands NIH contract worth as much as $44M

A Chester County biopharmaceutical company focused on antibiotics could receive as much as $44.2 million under a research and development contract it received from a division of the National Institute of Health. The contract was awarded to Venatorx Pharmaceuticals by the National Institute of Allergy and Infectious Diseases (NIAID). Malvern-based Venatorx will use the funds to advance a novel series of penicillin-binding protein inhibitors it is developing to target multi-drug resistant acinetobacter…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news